![Herbert S. Chow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Herbert S.
Chow is the founder of Hemstat, Inc. Prior to founding Hemstat, he worked as the Chief Technology Officer at Stellar Biotechnologies, Inc. from 2012 to 2014.
Chow received his undergraduate degree from The Ohio State University and his doctorate from the University of Illinois.
Anciens postes connus de Herbert S. Chow
Sociétés | Poste | Fin |
---|---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Directeur Technique/Scientifique/R&D | 10/12/2014 |
Hemstat, Inc. | Fondateur | - |
Formation de Herbert S. Chow
The Ohio State University | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
Hemstat, Inc. |